IDEXX LABORATORIES INC /DE Quarterly Retained Earnings (Accumulated Deficit) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Idexx Laboratories Inc /De quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q2 2010 to Q3 2024.
  • Idexx Laboratories Inc /De Retained Earnings (Accumulated Deficit) for the quarter ending September 30, 2024 was $5.12B, a 20.4% increase year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.12B +$866M +20.4% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $4.88B +$846M +20.9% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $4.68B +$867M +22.7% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $4.44B +$845M +23.5% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $4.25B +$823M +24% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $4.04B +$791M +24.4% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $3.81B +$699M +22.5% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $3.6B +$679M +23.3% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $3.43B +$670M +24.3% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $3.25B +$664M +25.7% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $3.11B +$735M +30.9% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $2.92B +$745M +34.2% Dec 31, 2021 10-K 2023-02-16
Q3 2021 $2.76B +$757M +37.8% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $2.58B +$728M +39.2% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $2.38B +$674M +39.5% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $2.18B +$580M +36.3% Dec 31, 2020 10-K 2022-02-16
Q3 2020 $2B +$496M +32.9% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $1.85B +$458M +32.8% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $1.71B +$435M +34.2% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $1.6B +$428M +36.6% Dec 31, 2019 10-K 2021-02-12
Q3 2019 $1.51B +$423M +39.1% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $1.4B +$407M +41.2% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $1.27B +$390M +44.3% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $1.17B +$364M +45.3% Dec 31, 2018 10-K 2020-02-14
Q3 2018 $1.08B +$317M +41.4% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $989M +$294M +42.4% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 $880M +$271M +44.5% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $804M +$263M +48.7% Dec 31, 2017 10-K 2019-02-15
Q3 2017 $765M +$277M +56.8% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 $695M +$263M +61% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 $609M +$245M +67.3% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $540M +$222M +69.7% Dec 31, 2016 10-K 2018-02-16
Q3 2016 $488M +$214M +78.1% Sep 30, 2016 10-Q 2016-11-01
Q2 2016 $432M +$201M +86.8% Jun 30, 2016 10-Q 2016-08-02
Q1 2016 $364M -$1.36B -78.8% Mar 31, 2016 10-Q 2016-04-29
Q4 2015 $318M -$1.36B -81% Dec 31, 2015 10-K 2017-02-17
Q3 2015 $274M -$1.38B -83.4% Sep 30, 2015 10-Q 2015-10-28
Q2 2015 $231M -$1.37B -85.5% Jun 30, 2015 10-Q 2015-07-30
Q1 2015 $1.72B +$182M +11.8% Mar 31, 2015 10-Q 2015-04-28
Q4 2014 $1.68B +$182M +12.2% Dec 31, 2014 10-K 2016-02-17
Q3 2014 $1.65B +$199M +13.7% Sep 30, 2014 10-Q 2014-10-24
Q2 2014 $1.6B +$193M +13.7% Jun 30, 2014 10-Q 2014-07-25
Q1 2014 $1.54B +$190M +14% Mar 31, 2014 10-Q 2014-04-25
Q4 2013 $1.49B +$188M +14.4% Dec 31, 2013 10-K 2015-02-17
Q3 2013 $1.45B +$188M +14.9% Sep 30, 2013 10-Q 2013-10-22
Q2 2013 $1.4B +$185M +15.2% Jun 30, 2013 10-Q 2013-07-23
Q1 2013 $1.35B +$182M +15.6% Mar 31, 2013 10-Q 2013-04-23
Q4 2012 $1.31B +$178M +15.8% Dec 31, 2012 10-K 2014-02-18
Q3 2012 $1.26B +$173M +15.9% Sep 30, 2012 10-Q 2012-10-19
Q2 2012 $1.22B +$169M +16% Jun 30, 2012 10-Q 2012-07-20
Q1 2012 $1.17B +$166M +16.6% Mar 31, 2012 10-Q 2012-04-20
Q4 2011 $1.13B +$162M +16.8% Dec 31, 2011 10-K 2013-02-19
Q3 2011 $1.09B +$160M +17.2% Sep 30, 2011 10-Q 2011-10-21
Q2 2011 $1.05B +$156M +17.5% Jun 30, 2011 10-Q 2011-07-22
Q1 2011 $1B Mar 31, 2011 10-Q 2011-04-21
Q4 2010 $966M Dec 31, 2010 10-K 2012-02-17
Q3 2010 $929M Sep 30, 2010 10-Q 2010-10-22
Q2 2010 $894M Jun 30, 2010 10-Q 2010-07-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.